Kat Okholm Kryger, PhD

UEFA Medical Specialist, Football Division

Short Abstract:

Women's health research in football is crucial for understanding the unique physiological, technological, and medical needs of female athletes. Historically, most sports science and medicine has focused on men, leading to gaps in knowledge about injury prevention, performance optimisation, and health risks specific to women. Recent studies have highlighted the importance of tailoring equipment and practices among female footballers. Addressing these issues through dedicated research has been requested by players and staff to enhance player safety, improve athletic performance, and promote gender equity, ensuring that female footballers receive the same level of support and resources as their male counterparts. This talk will discuss the status quo and challenges still faced by medical and performance staff in women’s football.

Short CV:

Kat Okholm Kryger is a medical specialist at UEFA. Her role involves research and knowledge transfer for medical topics in football - spanning across men’s and women’s football and from the grassroots to elite level. Kat has previously led medical research for women’s football at FIFA and possesses multiple academic roles at academic institutions in the UK. Kat has a MSc in Biomedical Engineering and a PhD in Sports Engineering (on the topic of football boots) and therefore enjoys work linking the technology and medical spheres in football.

Dr. Christoph Schranz

Head of New Technology, Hamilton Medical AG (Ems), Switzerland

Sebastian Wegner

 CEO, Sciospec Scientific Instruments GmbH, Bennewitz, Germany 

Short Abstract:

This keynote will cover the basics of electrical impedance spectroscopy (EIS) including fundamental principles, measurement setups, typical challenges for using them in practical applications and ways to safely apply impedance measurements in medical research. Special emphasis will be put on electrical impedance tomography (EIT), the imaging technique that is one of the most prominent medical applications for impedance-based technologies. Throughout all this, we will look into current trends and developments and have a look at some illustrative case studies.

Short CV:

Sebastian comes from an electrical engineering background with focus on electronics and sensor systems. In 2006 he started working on bioanalytical and cell-based applications of impedance spectroscopy, developing multichannel impedance setups for MEA sensors. Together with a highly motivated group of fellow engineers and scientists he went on to found Sciospec in 2010 and has been heading the company as CEO  ever since.

Marc D Breton, PhD

Associate Professor of Research, University of Virginia, School of Medicine & School of Engineering and Applied Sciences, Associate Director for Research, Center for Diabetes Technology, USA

Short Abstract: TBA

Short CV:

Dr. Marc D. Breton is Professor at the University of Virginia and Associate Director and co-founder of the Center for Diabetes Technology. He received a Master of Science in Automatic Control from Ecole Centrale de Lille, France in 2001 and a PhD in System Engineering from UVa in 2004. Dr Breton’s research is centered on bringing engineering techniques such as mathematical modeling, simulation, signal processing and automatic control into the field of medicine and clinical practice, with a focus on diabetes technology, in particular the assessment and control of sugar levels in type 1 diabetes mellitus. Dr. Breton’s research is funded by the National Institute of Health, the Juvenile Diabetes Research Foundation, and Industrial partners. Dr. Breton is author of over 150 peer-reviewed publications and holds more than 20 patents in the field of diabetes technology. Dr Breton and colleagues led the academic pursuit of Automated Insulin Delivery, and designed the algorithm at the center of the Tandem t:slim with Control-IQ system. For these achievements, Dr Breton received the 2022 Artificial Pancreas Award from the Diabetes Technology Society and the 2022 Edlich-Henderson Innovator of the Year Award.

Dr. Lars Mündermann

Director & Expert - Digital Health Technology, KARL STORZ SE & Co. KG, Germany

Short Abstract: TBA

Short CV:

Short Abstract:

Virtually all forms of healthcare are experiencing demand growth which outstrips the ability of people and society to pay, increasing rationing and inequity of access to care. These changes are strongly driven by the high-intensity interaction of aging demographics and increasing chronic disease. Respiratory disease affects major portions of population and costs up to 1% GDP, conservatively or 10% of healthcare expenditure. The primary form of care mixes pharmacotherapy, some physiotherapy, and a wide range of mechanical ventilation, whether they be outpatients with COPD or ICU patients with ARDS. This talk discusses how low-cost sensors and open, low-cost device designs can liberate data from hardware, increasing inter-operability, as well as the chance to automate and optimise all three major axes of care: 1) diagnosis; 2) monitoring; and 3) care delivery – all at potentially far lower cost in clinical personnel and overall care to patients and society.

Short CV:

Professor Geoff Chase is a Distinguished Professor of Engineering at the University of Canterbury in New Zealand. His research focuses on development, validation and clinical application of physiological models, primarily in intensive care, with a focus on saving lives and cost to increase the quality and equity of access to care. He is a Fellow of the Royal Society of NZ (FRSNZ) and American Society of Mechanical Engineers (FASME), and Distinguished Fellow of Engineering NZ (DistFEngNZ) with over 1600 scientific publication and patents, and has founded 3 venture funded start-ups.